AdCLD-CoV19-1 OMI
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AdCLD-CoV19-1 OMI, covering 2024-07-17 to 2024-11-15. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers [Phase 3]